Biohaven Ltd. short interest in 2024
In 2024, Biohaven Ltd.'s disclosed short interest ran from 8.14% of shares outstanding on 12 Jan 2024 to 9.61% on 31 Dec 2024, a change of +1.47 percentage points. The year's high was 12.07% on 28 Jun 2024 and its low 7.66% on 13 Dec 2024, averaging 10.11% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.52 days on 30 Aug 2024. Full history: Biohaven Ltd..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 8.14% (12 Jan 2024)
- End of year
- 9.61% (31 Dec 2024)
- Change
- +1.47 pp
- High
- 12.07% (28 Jun 2024)
- Low
- 7.66% (13 Dec 2024)
- Average
- 10.11%
- Highest days to cover
- 16.52 (30 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 8.14% | 5.44 | |
| 31 Jan 2024 | 8.34% | 7.17 | |
| 15 Feb 2024 | 7.96% | 8.58 | |
| 29 Feb 2024 | 9.48% | 8.22 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 10.58% | 4.45 | |
| 28 Mar 2024 | 10.50% | 6.01 | |
| 15 Apr 2024 | 10.93% | 8.33 | |
| 30 Apr 2024 | 11.81% | 5.48 | |
| 15 May 2024 | 11.33% | 7.44 | 10-Q filed, results (8-K) |
| 31 May 2024 | 12.04% | 5.46 | |
| 14 Jun 2024 | 11.35% | 10.94 | |
| 28 Jun 2024 | 12.07% | 5.72 | |
| 15 Jul 2024 | 12.02% | 11.63 | |
| 31 Jul 2024 | 12.00% | 10.88 | |
| 15 Aug 2024 | 10.88% | 13.27 | results (8-K), 10-Q filed |
| 30 Aug 2024 | 10.80% | 16.52 | |
| 13 Sep 2024 | 10.56% | 13.30 | |
| 30 Sep 2024 | 9.50% | 5.23 | |
| 15 Oct 2024 | 9.87% | 7.37 | |
| 31 Oct 2024 | 9.68% | 13.10 | |
| 15 Nov 2024 | 7.74% | 9.83 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 7.75% | 8.78 | |
| 13 Dec 2024 | 7.66% | 10.03 | |
| 31 Dec 2024 | 9.61% | 7.16 |
See also: Biohaven Ltd.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.